This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rosser, T. Articles by Packer, R. J. Search for Related Content PubMed PubMed Citation Articles by Rosser, T. Articles by Packer, R. J. Social Bookmarking                         What's this?

Review Article : Neurofibromas in Children With Neurofibromatosis 1

Department of Neurology and Pediatrics Center for Neuroscience and Behavioral Medicine, Children's National Medical Center, The George Washington University, Washington, DC

Roger J. Packer, MD

Department of Neurology and Pediatrics Center for Neuroscience and Behavioral Medicine, Children's National Medical Center, The George Washington University, Washington, DC

Neurofibromatosis 1 is a common autosomal dominant disease reported in approximately 1 in 3000 individuals. Although some features of neurofibromatosis 1, such as café-au-Iait spots and Lisch nodules, are clinically silent, neurofibromas cause a significant degree of morbidity, mortality, and cosmetic disfigurement. Childhood through early adulthood is a vulnerable period for the growth of these lesions. Neurofibromas are a heterogeneous group of benign tumors that grow from intraneural and extraneural tissues. These tumors take on different morphology, grow at variable rates, and occur in multiple locations. Symptoms arise as neurofibromas enlarge, compressing and distorting local structures. The unpredictable nature of neurofibromas has a serious impact on the quality of life of patients with neurofibromatosis 1, and their management is challenging for physicians. Surgical removal remains the mainstay of treatment. However, advances in the understanding of the genetics and pathogenesis of neurofibromatosis 1 have led to the development of promising new biologically directed therapies. The purpose of this review is to summarize the defining characteristics, incidence, clinical course, management options, and outcome of neurofibromas in children with neurofibromatosis 1. (J Child Neurol 2002;17:585-591).

Journal of Child Neurology, Vol. 17, No. 8, 585-591 (2002)
DOI: 10.1177/088307380201700808


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?